Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Our experience in diagnostic and treatment of idiopathic juxtafoveal telangiectasia with macular edema

Poster Details

First Author: K.Svidko UKRAINE

Co Author(s):    V. Sardaryan   Y. Kovalenko   N. Selivanova   K. Tkachenko   L. Kayrkina  

Abstract Details


Make diagnostic criterias and estimate effect of anti-VEGF therapy in macular edema.


International Medical Centre Oftalmika


We analyzed and observed 3 patients (6 eyes, age 35-55years) with idiopathic juxtafoveal telangiectasia during the period from 8 to 12 monthes. Keratorefractometry, visometry, pneumotonometry, static perimetry, contact biomicroscopy, optical coherence tomography and fluorescent angiography were conducted for patients.


in 5 eyes central scotoma, parafoveal telangiectasia, hard exudates, fovea swelling were observed. OCT showed: atypical edema with thinning of inner limiting membrane, parafoveal hyperreflective areas. During fluorescent angiography ectatic parafoveal capillaries with changed permeability of vascular wall were observed. Reduction of sensitivity, single parafoveal telangiectasia without additional changes in the macula and no leakage during fluorescent angiography were found in one eye. Anti-VEGF therapy was performed three times with interval of 1-1.5 months. During 8-12 months visual acuity was stable or better. On OCT scans was decreased foveal retinal thickness due to the partial or complete resorption of edema.


Diagnostic criterias for idiopathic juxtafoveal telangiectasia are typical changes of the retina, that can be found during contact biomicroscopy, fluorescent angiography and OCT. Anti-VEGF therapy was effective and can be used as a method of treatment of idiopathic juxtafoveal telangiectasia.

Financial Disclosure:


Back to Poster listing